In this paper, we explore the multifaceted applications of GenAI across three important areas:

  1. Revolutionizing drug discovery and research
  2. Improving launch and commercial performance
  3. Supporting clinical decision making
    and patient care

We summarize the potential use cases for large language models (LLMs) in the world of pharma and healthcare – and offer guidance on the key aspects that require a cautious approach to ensure patient safety and ethical integrity.

In recent years, there has been an exponential rise in the use of artificial intelligence (AI) technologies within the pharmaceutical sector – fuelling advancements while reshaping the drug discovery process, optimizing clinical trials, and improving launch performance. The healthcare sector also stands at the forefront of AI integration, harnessing its capabilities to enhance patient care, navigate the complexities of diagnosis and treatment, while driving personalized medicine and innovation.

Download the whitepaper

"*" indicates required fields

Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.
This field is for validation purposes and should be left unchanged.